8.66 0.09 (1.05%)

New 52W Low in past week

646.5K XNAS Volume

XNAS 20 Mar, 2025 4:03 PM (EDT)

Board Meeting
The next board meeting for Immunome Inc is on 28 Mar 2025 for the purpose of Immunome Inc Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Immunome Inc

The latest disclosure was made by Clay B. Siegall in Immunome Inc where a trade of 150,000 Common Stock done at an average price of $7.8 was reported to US exchanges on Jan. 31, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Clay B. Siegall Director, President and CEO Purchase of securities on an exchange or from another person at price $ 7.75 per share. 31 Jan 2025 150,000 669,636 - 7.8 1,162,500 Common Stock
Philip Tsai Chief Technology Officer Purchase of securities on an exchange or from another person at price $ 9.43 per share. 21 Nov 2024 21,000 21,000 - 9.4 198,030 Common Stock
Robert Lechleider Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 9.48 per share. 21 Nov 2024 15,805 15,805 - 9.5 149,800 Common Stock
Clay B. Siegall Director, President and CEO Purchase of securities on an exchange or from another person at price $ 9.78 per share. 21 Nov 2024 33,943 519,636 - 9.8 331,918 Common Stock
Clay B. Siegall Director, President and CEO Purchase of securities on an exchange or from another person at price $ 9.54 per share. 21 Nov 2024 66,057 485,693 - 9.5 630,263 Common Stock
Max Rosett Chief Financial Officer Sale of securities on an exchange or to another person at price $ 16.01 per share. 19 Sep 2024 14,380 47,476 - 16.0 230,224 Common Stock
Max Rosett Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Sep 2024 42,000 91,848 - - Stock option (right to buy)
Max Rosett Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. 19 Sep 2024 42,000 61,856 - 1.1 44,100 Common Stock
Jack Higgins Chief Scientific Officer Gift of securities by or to the insider at price $ 0.00 per share. 15 Aug 2024 2,471 13,529 - 0 Common Stock
Jack Higgins Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 15 Aug 2024 19,524 179,040 - - Stock option (right to buy)
Jack Higgins Chief Scientific Officer Sale of securities on an exchange or to another person at price $ 13.93 per share. 15 Aug 2024 3,524 16,000 - 13.9 49,072 Common Stock
Jack Higgins Chief Scientific Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.35 per share. 15 Aug 2024 19,524 19,524 - 1.3 26,357 Common Stock
Robert Lechleider Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 200,000 200,000 - - Stock option (right to buy)
Max Rosett EVP, Operations & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 190,000 190,000 - - Stock option (right to buy)
Jack Higgins Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 190,000 190,000 - - Stock option (right to buy)
Bruce Turner Chief Strategy Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 110,000 110,000 - - Stock option (right to buy)
Kinney Horn CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 130,000 130,000 - - Stock option (right to buy)
Sandra G. Stoneman CHIEF LEGAL OFFICER & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 210,000 210,000 - - Stock option (right to buy)
Clay B. Siegall Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2024 800,000 800,000 - - Stock option (right to buy)
Philip Tsai Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2024 250,000 250,000 - - Stock option (right to buy)
Carol A. Schafer Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 11,333 11,333 - - Stock option (right to buy)
Philip Wagenheim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 11,333 11,333 - - Stock option (right to buy)
James P. Boylan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 11,333 11,333 - - Stock option (right to buy)
Isaac Barchas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 11,333 11,333 - - Stock option (right to buy)
Sandra M. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 11,333 11,333 - - Stock option (right to buy)
Clay B. Siegall Director, President and CEO Purchase of securities on an exchange or from another person at price $ 13.91 per share. 20 May 2024 79,566 399,202 - 13.9 1,106,524 Common Stock
Clay B. Siegall Director, President and CEO Purchase of securities on an exchange or from another person at price $ 13.78 per share. 20 May 2024 20,434 419,636 - 13.8 281,548 Common Stock
Max Rosett EVP, Operations & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 May 2024 30,000 30,000 - - Stock option (right to buy)
Sandra M. Swain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2024 25,737 25,737 - - Stock option (right to buy)
Kinney Horn CHIEF BUSINESS OFFICER Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2024 300,000 300,000 - - Stock option (right to buy)
G. Sandra Stoneman CHIEF LEGAL OFFICER & GC Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 200,000 200,000 - - Stock option (right to buy)
Rosett Max EVP, OPERATIONS & INTERIM CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jan 2024 175,000 175,000 - - Stock option (right to buy)
A. Schafer Carol Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jan 2024 32,934 32,934 - - Stock option (right to buy)
Phil Noland Roberts Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Dec 2023 275,000 275,000 - - Stock option (right to buy)
Jack Higgins Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2023 200,000 200,000 - - Stock option (right to buy)
Matthew K. Robinson Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 58,000 58,000 - - Stock Option (Right to Buy)
Corleen M. Roche Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 58,000 58,000 - - Stock Option (Right to Buy)
Dennis H. Giesing Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 50,000 50,000 - - Stock Option (Right to Buy)
Sandra G. Stoneman General Counsel and CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 56,000 56,000 - - Stock Option (Right to Buy)
Michael Lefenfeld Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 6,500 6,500 - - Stock Option (Right to Buy)
Purnanand D. Sarma Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 166,500 166,500 - - Stock Option (Right to Buy)
Philip Wagenheim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 6,500 6,500 - - Stock Option (Right to Buy)
Richard A. Baron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 6,500 6,500 - - Stock Option (Right to Buy)
John L. LaMattina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 6,500 6,500 - - Stock Option (Right to Buy)
Franklyn G Prendergast Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Jun 2023 6,500 6,500 - - Stock Option (Right to Buy)
Michael Lefenfeld Director Grant, award, or other acquisition of securities at price $ 4.00 per share. 15 Jan 2023 13,875 40,747 - 4 55,500 Common Stock
Philip Wagenheim Director Grant, award, or other acquisition of securities at price $ 4.00 per share. 15 Jan 2023 8,750 406,147 - 4 35,000 Common Stock
John L. LaMattina Director Grant, award, or other acquisition of securities at price $ 4.00 per share. 15 Jan 2023 15,125 66,953 - 4 60,500 Common Stock
Matthew K. Robinson Chief Technology Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 35,000 35,000 - - Stock Option (Right to Buy)
Corleen M. Roche Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 70,000 70,000 - - Stock Option (Right to Buy)
Dennis H. Giesing Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 60,000 60,000 - - Stock Option (Right to Buy)
Sandra G. Stoneman General Counsel and CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 43,000 43,000 - - Stock Option (Right to Buy)
Michael Lefenfeld Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 6,500 6,500 - - Stock Option (Right to Buy)
Purnanand D. Sarma Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 121,000 121,000 - - Stock Option (Right to Buy)
Philip Wagenheim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 6,500 6,500 - - Stock Option (Right to Buy)
Richard A. Baron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 6,500 6,500 - - Stock Option (Right to Buy)
John L. LaMattina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 6,500 6,500 - - Stock Option (Right to Buy)
Franklyn G Prendergast Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2022 6,500 6,500 - - Stock Option (Right to Buy)
Richard A. Baron Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.38 per share. 18 Aug 2021 2,343 2,343 - 11.4 26,663 Common Stock
Richard A. Baron Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Aug 2021 2,343 5,157 - - Stock Option (Right to Buy)
Franklyn G Prendergast Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2021 7,500 7,500 - - Stock Option (Right to Buy)
Purnanand D. Sarma Director, president and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 93,354 93,354 - - Stock Option (Right to Buy)
John L. LaMattina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 3,750 3,750 - - Stock Option (Right to Buy)
Richard A. Baron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 3,750 3,750 - - Stock Option (Right to Buy)
Philip Wagenheim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 3,750 3,750 - - Stock Option (Right to Buy)
Michael Lefenfeld Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 3,750 3,750 - - Stock Option (Right to Buy)
Michael Widlitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 3,750 3,750 - - Stock Option (Right to Buy)
Sandra G. Stoneman General Counsel and CLO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 16,609 16,609 - - Stock Option (Right to Buy)
Dennis H. Giesing Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 16,609 16,609 - - Stock Option (Right to Buy)
Corleen M. Roche Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 May 2021 16,609 16,609 - - Stock Option (Right to Buy)
Purnanand D. Sarma Director, President and CEO Purchase of securities on an exchange or from another person at price $ 18.41 per share. 25 May 2021 10,500 10,500 - 18.4 193,305 Common Stock
John L. LaMattina Director Purchase of securities on an exchange or from another person at price $ 18.44 per share. 24 May 2021 338 46,726 - 18.4 6,233 Common Stock
John L. LaMattina Director Purchase of securities on an exchange or from another person at price $ 18.58 per share. 24 May 2021 5,102 51,828 - 18.6 94,795 Common Stock
Philip Wagenheim Director Purchase of securities on an exchange or from another person at price $ 18.35 per share. 24 May 2021 13,500 397,397 - 18.4 247,725 Common Stock
Michael Lefenfeld Director Purchase of securities on an exchange or from another person at price $ 17.80 per share. 24 May 2021 600 22,822 - 17.8 10,680 Common Stock
Michael Lefenfeld Director Purchase of securities on an exchange or from another person at price $ 19.03 per share. 24 May 2021 1,335 26,872 - 19.0 25,405 Common Stock
Michael Lefenfeld Director Purchase of securities on an exchange or from another person at price $ 18.44 per share. 24 May 2021 2,715 25,537 - 18.4 50,065 Common Stock
Corleen M. Roche Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Apr 2021 125,000 125,000 - - Stock Option (Right to Buy)
Dennis H. Giesing Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Mar 2021 125,000 125,000 - - Stock Option (Right to Buy)
Richard A. Baron Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2020 7,500 7,500 - - Stock Option (Right to Buy)
Philip Wagenheim Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2020 7,500 7,500 - - Stock Option (Right to Buy)(1)
Michael Lefenfeld Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2020 7,500 7,500 - - Stock Option (Right to Buy)
Michael Widlitz Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2020 7,500 7,500 - - Stock Option (Right to Buy)
Sandra G. Stoneman Chief Legal Officer & Gen Coun Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2020 148,837 148,837 - - Employee Stock Option (Right to Buy)
John L. Lamattina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Nov 2020 7,500 7,500 - - Stock Option (Right to Buy)
Michael Lefenfeld Director 06 Oct 2020 22,222 22,222 - - Common Stock
Michael Lefenfeld Director 06 Oct 2020 22,222 0 - - Series A Convertible Preferred Stock
Michael Lefenfeld Director 06 Oct 2020 11,111 0 - - Warrant (right to buy)
Michael Lefenfeld Director 06 Oct 2020 11,111 11,111 - - Warrant (right to buy)
John L. Lamattina Director 06 Oct 2020 11,111 0 - - Warrant (right to buy)
John L. Lamattina Director 06 Oct 2020 46,388 46,388 - - Common Stock
John L. Lamattina Director 06 Oct 2020 46,388 0 - - Series A Convertible Preferred Stock
John L. Lamattina Director 06 Oct 2020 11,111 11,111 - - Warrant (right to buy)
Michael Widlitz Director 06 Oct 2020 51,315 51,315 - - Common Stock
Michael Widlitz Director 06 Oct 2020 51,315 0 - - Series A Convertible Preferred Stock
Richard F. Fitzgerald Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 7,681 7,681 - - Employee Stock Option (right to buy)
Richard F. Fitzgerald Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2020 104,802 104,802 - - Employee Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures